These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31727279)
41. Molecular and clinical implementations of ovarian cancer mouse avatar models. Zayed AA; Mandrekar SJ; Haluska P Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297 [TBL] [Abstract][Full Text] [Related]
42. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer. Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585 [TBL] [Abstract][Full Text] [Related]
44. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer. Davies AH; Wang Y; Zoubeidi A Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377 [TBL] [Abstract][Full Text] [Related]
45. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554 [TBL] [Abstract][Full Text] [Related]
46. Integrated analysis of transcriptome in cancer patient-derived xenografts. Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608 [TBL] [Abstract][Full Text] [Related]
47. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer. Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199 [TBL] [Abstract][Full Text] [Related]
48. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Gong JH; Liu XJ; Li Y; Zhen YS Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160 [TBL] [Abstract][Full Text] [Related]
49. Method for Generating a Patient-Derived Xenograft Model of CLL. Chen SS Methods Mol Biol; 2019; 1881():165-171. PubMed ID: 30350205 [TBL] [Abstract][Full Text] [Related]
51. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract. Damhofer H; Ebbing EA; Steins A; Welling L; Tol JA; Krishnadath KK; van Leusden T; van de Vijver MJ; Besselink MG; Busch OR; van Berge Henegouwen MI; van Delden O; Meijer SL; Dijk F; Medema JP; van Laarhoven HW; Bijlsma MF J Transl Med; 2015 Apr; 13():115. PubMed ID: 25884700 [TBL] [Abstract][Full Text] [Related]
52. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification. Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950 [TBL] [Abstract][Full Text] [Related]
53. Patient-derived xenografts as in vivo models for research in urological malignancies. Inoue T; Terada N; Kobayashi T; Ogawa O Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952 [TBL] [Abstract][Full Text] [Related]
59. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878 [TBL] [Abstract][Full Text] [Related]
60. Comparison of GFP-Expressing Imageable Mouse Models of Human Esophageal Squamous Cell Carcinoma Established in Various Anatomical Sites. Hu T; Qi H; Li P; Zhao G; Ma Y; Hao Q; Gao C; Zhang Y; Wang C; Yang M; Hoffman RM; Chen P; Dong Z Anticancer Res; 2015 Sep; 35(9):4655-63. PubMed ID: 26254355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]